Free Trial

Vestmark Advisory Solutions Inc. Takes Position in Teladoc Health, Inc. (NYSE:TDOC)

Teladoc Health logo with Medical background
Remove Ads

Vestmark Advisory Solutions Inc. bought a new position in Teladoc Health, Inc. (NYSE:TDOC - Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The firm bought 63,270 shares of the health services provider's stock, valued at approximately $575,000.

Other hedge funds have also modified their holdings of the company. Lindbrook Capital LLC raised its stake in Teladoc Health by 78.9% in the fourth quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider's stock worth $33,000 after buying an additional 1,612 shares in the last quarter. Arizona State Retirement System boosted its stake in shares of Teladoc Health by 1.8% in the fourth quarter. Arizona State Retirement System now owns 49,691 shares of the health services provider's stock worth $452,000 after acquiring an additional 859 shares during the last quarter. Aigen Investment Management LP purchased a new stake in shares of Teladoc Health in the fourth quarter valued at approximately $186,000. Proficio Capital Partners LLC acquired a new stake in shares of Teladoc Health during the 4th quarter worth about $510,000. Finally, Charles Schwab Investment Management Inc. boosted its position in shares of Teladoc Health by 18.7% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,443,713 shares of the health services provider's stock worth $22,213,000 after buying an additional 384,528 shares during the period. 76.82% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

TDOC has been the subject of several analyst reports. Needham & Company LLC reiterated a "hold" rating on shares of Teladoc Health in a report on Thursday, February 27th. The Goldman Sachs Group cut their price objective on Teladoc Health from $16.00 to $13.00 and set a "buy" rating for the company in a research report on Monday, March 3rd. Piper Sandler cut their target price on shares of Teladoc Health from $13.00 to $12.00 and set an "overweight" rating for the company in a research report on Thursday, February 27th. Oppenheimer lowered their price objective on Teladoc Health from $14.00 to $12.00 and set an "outperform" rating for the company in a research report on Friday, January 24th. Finally, Royal Bank of Canada increased their target price on shares of Teladoc Health from $11.00 to $12.00 and gave the stock an "outperform" rating in a research report on Friday, January 24th. Eleven research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Hold" and an average price target of $11.26.

Remove Ads

View Our Latest Analysis on TDOC

Teladoc Health Stock Down 1.4 %

Shares of NYSE TDOC traded down $0.13 during trading hours on Wednesday, hitting $8.88. The company had a trading volume of 7,135,485 shares, compared to its average volume of 8,315,473. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. The firm's 50 day moving average is $10.61 and its 200-day moving average is $9.69. The stock has a market capitalization of $1.54 billion, a P/E ratio of -1.54 and a beta of 1.27. Teladoc Health, Inc. has a 1-year low of $6.76 and a 1-year high of $15.68.

Teladoc Health (NYSE:TDOC - Get Free Report) last announced its earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.21) by ($0.07). The business had revenue of $640.49 million during the quarter, compared to the consensus estimate of $639.44 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. On average, analysts expect that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.

About Teladoc Health

(Free Report)

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

See Also

Institutional Ownership by Quarter for Teladoc Health (NYSE:TDOC)

Should You Invest $1,000 in Teladoc Health Right Now?

Before you consider Teladoc Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.

While Teladoc Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own in 2025 Cover

Enter your email address and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Will Tesla’s Robot Future Save Its Falling Stock?
NVIDIA’s Dip Is a Gift—Here’s Why It Won’t Last
Best ETFs for Spring 2025: Strong and Steady Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads